Thetryptophan depleting enzyme indoleamine 2,3-dioxygenase (IDO) is alsobeneficial in EAE disease models of MS [52, 54], where IDO expression inmicroglia is tightly regulated by cytokines during inflammation [51–53]. Here, IDO1 is linked to myeloid sarcoma.